← Back to Patent Explorer
US4230719A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid and pharmaceutically acceptable salt thereof and method for treating symptoms of inflammation and pain

Assignee: Toyama Chemical Co Ltd
•
Filing: 1979-08-31
•
Granted: 1980-10-28
•
Expires: 1999-08-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid and a pharmaceutically acceptable salt thereof. These compounds are useful for treating symptoms of inflammation and pain in mammals including man. This disclosure relates to such compounds, a process for producing the same, a pharmaceutical composition containing such a compound and a method for treating symptoms of inflammation and pain.

Inventors

  • 👤 Tsutomu Kodama
  • 👤 Masao Nakabayashi
  • 👤 Isao Watanabe
  • 👤 Hiroshi Hirano
  • 👤 Norio Abe
  • 👤 Katsufumi Tanaka
  • 👤 Hirotoshi Arai

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 21:40
CPC Classifications
C; C07; C07D; C07D263/00; C07D263/02; C07D263/08; C07D263/10; C07C; C07C41/00; C07C41/48; C07C41/50; C07C41/56; C07C45/00; C07C45/56; C07C45/57; C07C45/58; C07C51/00; C07C51/16; C07C51/29; C07D303/00; C07D303/02; C07D303/08; C07D333/00; C07D333/02; C07D333/04; C07D333/06; C07D333/22; C07D333/24

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 13 words
2-[4-(3-methyl-2-thienyl)phenyl]propionic acid represented by the formula, ##STR46## or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 13 words
2-[4-(3-methyl-2-thienyl)phenyl]propionic acid represented by the formula, ##STR46## or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 8 words
d-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 8 words
d-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 8 words
dl-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid or a pharmaceutically acceptable salt thereof.
Claim 6
Dependent Claim 8 words
dl-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim 18 words
A pharmaceutical composition containing a compound as claimed in claim 1, 2 or 3 as pharmaceutically active ingredient.
Claim 8
Dependent Claim 22 words
A pharmaceutical composition as claimed in claim 4, wherein the amount of the active ingredient per unit is 10 to 100 mg.
Claim 9
Dependent Claim 36 words
A method for alleviating the symptoms of inflammation and pain, which comprises administering to an animal suffering from such symptoms 0.1 to 50 mg/kg dialy of a compound as claimed in claim 1, 2 or 3.
Claim 10
Dependent Claim 16 words
The method according to claim 6, wherein the inflammation and the pain are caused by rheumatism.

References Cited (Backward Citations)

GB1119334A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-10-28 1984-04-28 1984-10-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-10-28 1988-04-28 1988-10-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-10-28 1992-04-28 1992-10-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag